Impaired cognitive executive dysfunction in adult treated hypertensives with a confirmed diagnosis of poorly controlled blood pressure

International Journal of Medical Sciences

Volumn 11, Issue 8, 2014, Pages 771-778

  Spinelli, Christian ^a   De Caro, Maria Fara ^a   Schirosi, Gabriella ^a   Mezzapesa, Domenico ^a   De Benedittis, Lorenzo ^a   Chiapparino, Concetta ^a   Serio, Gabriella ^a   Federico, Francesco ^a   Nazzaro, Pietro ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Ambulatory blood pressure monitoring; Blood pressure control; Cognitive dysfunction; Executive impairment

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ANTIHYPERTENSIVE AGENT;

ADULT; AGE; ARTERIAL WALL THICKNESS; ARTICLE; ATTENTION DISTURBANCE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; BLOOD VESSEL INJURY; CLOCK DRAWING; COGNITIVE DEFECT; EDUCATION; EXECUTIVE FUNCTION; FEMALE; FRONTAL ASSESSMENT BATTERY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGIC TEST; SEX DIFFERENCE; STROOP TEST; SYSTOLIC BLOOD PRESSURE; VERBAL FLUENCY; AGED; BLOOD PRESSURE; CLASSIFICATION; COGNITION DISORDERS; COMPLICATION; MASKED HYPERTENSION; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; RISK FACTOR; WHITE COAT HYPERTENSION;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; COGNITION DISORDERS; EXECUTIVE FUNCTION; FEMALE; HUMANS; MALE; MASKED HYPERTENSION; MIDDLE AGED; RISK FACTORS; WHITE COAT HYPERTENSION;

EID: 84901850190     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.8147     Document Type: Article

References (47)

1. Viswanathan A, Rocca WA, Tzourio C. Vascular risk factors and dementia. How to move forward? Neurology 2009; 72: 368-374.
2. Duron E, Hanon O. Vascular risk factors, cognitive decline, and dementia. Vasc Health Risk Manag. 2008; 4:363-381.
3. Cherbuin N, Reglade-Meslin C, Kumar R et al. Risk factors of transition from normal cognition to mild cognitive disorder: the PATH through Life Study. Dement Geriatr Cogn Disord 2009; 28:47-55.
4. Kilander L, Nyman H, Boberg M. et al. Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men. Hypertension 1998; 31:780-786.
5. Knecht S, Wersching H, Lohmann H et al. High-normal blood pressure is associated with poor cognitive performance. Hypertension 2008; 51: 663-668.
6. McGuinness B, Todd S, Passmore P et al. Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia. Cochrane Database Syst Rev 2009; 7:CD004034
7. Peters R, Beckett N, Forette F et al. for HYVET investigators. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial. The Lancet Neurology 2008; 7: 683-689.
8. Lithell H, Hansson L, Skoog I et al. for SCOPE Study Group. The study on cognition and prognosis in the elderly (SCOPE): principal results of a randomized double-blind intervention trial. Journal of Hypertension 2003; 21: 875-886
9. Birns J, Morris R, Donaldson N et al. The effects of blood pressure reduction on cognitive function: a review of effects based on pooled data from clinical trials. J Hypertens 2006; 24:1907-1914.
10. Touboul PJ, Hennerici MG, Meairs S et al. Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis 2007; 23:75-80.
11. Mancia G, De Backer G, Dominiczak A et al. for ESH-ESC Task Force on the Management of Arterial Hypertension. 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. ESC-ESH 2007 Guidelines. J Hypertens. 2007; 25:1751-1762
12. Pickering TG, Eguchi K, Kario K. Masked hypertension: a review. Hypertens Res 2007; 30:479-488
13. Measso G, Cavarzeran F, Zappalà G et al. The Mini-Mental State Examination: normative study of a random sample of Italian population. Dev Neuropsychol 1993; 9: 77-85
14. Appollonio I, Leone M, Isella V et al. The frontal Assesment Battery (FAB): normative values in an Italian population sample. Neurological Sciences 2005; 26:108-116.
15. Bianchi A, Dai Prà M. Twenty years after Spinnler and Tognoni: new instruments in the Italian neuropsychologist's toolbox. Neurological Sciences September 2008; 29: 209-217
16. Orsini A, Grossi D, Capitani E et al. Verbal and spatial immediate memory span: normative data from 1355 adults and 1112 children. Italian Journal of Neurological Sciences 1987; 8:539-548.
17. Carlesimo GA, Caltagirone C, Gainotti G. The Mental Deterioration Battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. The Group for the Standardization of the Mental Deterioration Battery. Eur Neurol 1996; 36: 378-38
18. Caffarra P, Vezzadini G, Dieci F et al. Una Versione Abbreviata Del Test Di Stroop: Dati Normativi Nella Popolazione Italiana. Nuova Rivista Di Neurologia 2002; 12: 111-115
19. Mondini S, Mapelli D, et al. Esame Neuropsicologico Breve - una batteria di test per lo screening neuropsicologico. Milano, Italy: Raffaello Cortina Editore; 2003.
20. Pickering TG, White WB, Giles TD, et al. When and how to use self (home) and ambulatory blood pressure monitoring. J Am Soc Hypertens 2010; 4: 56-61.
21. Tanya MS, Thomas GP, Joseph ES et al. The impact of perceived hypertension status on anxiety and the white coat effect. Annals of Behavioral Medicine 2007; 34: 1-9.
22. Muldoon MF, Nazzaro P, Sutton-Tyrrell K et al. White coat hypertension and carotid artery atherosclerosis: a matching study. Arch Intern Med 2000; 160:1507-1512
23. Suemoto CK, Nitrini R, Grinberg LT et al. Atherosclerosis and dementia: a cross-sectional study with pathological analysis of the carotid arteries. Stroke. 2011; 42: 3614-5.
24. Wetherell JL, Reynolds CA, Gatz M, et al. Anxiety, cognitive performance, and cognitive decline in normal aging. J Gerontol B Psychol Sci Soc Sci. 2002; 57: 246-55.
25. Shah K, Qureshi SU, Johnson M et al. Does use of antihypertensive drugs affect the incidence or progression of dementia? A systematic review. Am J Geriatr Pharmacother 2009; 7: 250-261.
26. Shlyakhto E. Observational Study on Cognitive function And systolic blood pressure Reduction (OSCAR): preliminary analysis of 6-month data from > 10,000 patients and review of the literature. Curr Med Res Opin 2007; 23 (Suppl 5):S13-S18.
27. Qiu C, Winblad B, Fratiglioni L. The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol 2005; 4:487-499.
28. Joosten H, van Eersel MEA, Gansevoort RT et al. Cardiovascular risk profile and cognitive function in young, middle-aged and elderly subjects. Stroke 2013; 44: 1543-1549.
29. Gupta R, Solanki RK, Pathak V. Blood pressure is associated with cognitive impairment in young hypertensives. World J Biol Psychiatry 2008; 9: 43-50.
30. Raz N, Rodrigue KM, Acker JD. Hypertension and the brain: vulnerability of the prefrontal regions and executive functions. Behav Neurosci 2003; 117: 1169-1180.
31. Harrington F, Saxby BK, McKeith IG et al. Cognitive performance in hypertensive and normotensive older subjects. Hypertension 2000; 36:1079-1082.
32. Swan GE, Carmelli D, Larue A. Systolic blood pressure tracking over 25 to 30 years and cognitive performance in older adults. Stroke 1998; 29: 2334-2340.
33. Sierra C, De La Sierra A, Salamero M et al. Silent cerebral white matter lesions and cognitive function in middle-aged essential hypertensive patients. Am J Hypertens 2004; 17: 529-534.
34. Gons RA, de Laat KF, van Norden AG et al. Hypertension and cerebral diffusion tensor imaging in small vessel disease. Stroke 2010; 41: 2801-2806.
35. Cummings JL. Frontal-subcortical circuits and human behavior. Arch Neurol 1993;50: 873-880.
36. Prins ND, van Dijk EJ, den Heijer T et al. Cerebral small-vessel disease and decline in information processing speed, executive function and memory. Brain 2005; 128: 2034-2041.
37. O'Sullivan M, Jarosz JM, Martin RJ, et al. MRI hyperintensities of the temporal lobe and external capsule in patients with CADASIL. Neurology 2001;56: 628-634.
38. Dufouil C, Chalmers J, Coskun O et al. PROGRESS MRI Substudy Investigators. Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy. Circulation 2005; 112: 1644-1650.
39. Saleh C. Carotid artery intima media thickness: a predictor of cognitive impairment? Front Biosci 2010; 2: 980-990.
40. Birns J, Kalra L. Cognitive function and hypertension. J Hum Hypertens 2009; 23: 86-96.
41. Paran E, Anson O, Reuveni H. Blood pressure and cognitive functioning among independent elderly. Am J Hypertens 2003; 16: 818-826.
42. Nazzaro P, Schirosi G, Mezzapesa D et al. Effect of clustering of metabolic syndrome factors on capillary and cerebrovascular impairment. Eur J Intern Med 2013; 24: 183-188.
43. Beason-Held LL, Moghekar A, Zonderman AB et al. Longitudinal changes in cerebral blood flow in the older hypertensive brain. Stroke 2007; 38:1766-1773.
44. Efimova IY, Efimova NY, Triss SV et al. Brain perfusion and cognitive function changes in hypertensive patients. Hypertens Res 2008; 31: 673-678.
45. Kuller LH, Lopez OL, Newman A et al. Risk factors for dementia in the cardiovascular health cognition study. Neuroepidemiology. 2003; 22: 13-22.
46. Igase M, Kohara K, Miki T. The association between hypertension and dementia in the elderly. Int J Hypertens 2012; doi 10.1155/2012/320648.
47. Hajjar I, Hart M, Chen YL et al. Effect of antihypertensive therapy on cognitive function in early executive cognitive impairment: a double blind randomized clinical trial. Arch Intern Med 2012; 172: 442-444.